Non-Invasive Prenatal Testing (NIPT) is a highly accurate and safe method for prenatal genetic testing that helps assess the risk of certain chromosomal abnormalities in the developing baby during pregnancy. By analyzing small fragments of fetal DNA present in the mother’s blood, NIPT can effectively detect common chromosomal abnormalities, including:
- Trisomy 21 (Down syndrome)
- Trisomy 18 (Edwards syndrome)
- Trisomy 13 (Patau syndrome)
- Sex chromosome aneuploidies (e.g., Turner syndrome, Klinefelter syndrome).
This innovative approach is a significant advancement in reproductive genomics, providing expectant parents with valuable information about their baby's health.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.